Literature DB >> 2555627

Unusually rapid development of a HBsAG-positive liver cirrhosis after liver transplantation.

H U Lautz1, R Müller, C Wittekind, S Mauz, H Barg-Hock, B Ringe, R Pichlmayr, F W Schmidt.   

Abstract

We report the case of a 44-year-old man who was transplanted in 1986 for hepatocellular carcinoma in a HBsAG-positive liver cirrhosis. The patient had no severe complications postoperatively. He received passive immunization for the prevention of hepatitis B reinfection during the first 6 months after liver grafting. Twelve months after the transplantation the new liver was reinfected with hepatitis B virus. Without any clinical or laboratory signs of severe hepatitis, the patient developed a histologically proven complete liver cirrhosis within 8 months after reinfection of the graft. The reasons for this might have been, first, a deleterious course of the infection under immunosuppressive therapy, and, second, the additional influence of a postoperatively acquired CMV infection or the combined toxic influence of cyclosporin A and its metabolites on the acute inflammation in the liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555627     DOI: 10.1007/BF01727009

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  What is the effect of a cytomegalovirus infection when superimposed on HBsAg-positive chronic hepatitis?

Authors:  C Vandelli; A Zannini; V Piaggi; M Melegari; R Battilani; E Ventura
Journal:  J Hepatol       Date:  1987-06       Impact factor: 25.083

2.  Renal transplantation and hepatitis B.

Authors:  J L Dienstag
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Liver transplantation in the adult.

Authors:  R Y Calne; R Williams; K Rolles
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

Review 4.  Liver transplantation today.

Authors:  J W Marsh; L Makowka; S Todo; R D Gordon; C O Esquivel; A Tzakis; S Iwatsuki; T E Starzl
Journal:  Postgrad Med       Date:  1987-04       Impact factor: 3.840

5.  Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry.

Authors:  H Bismuth; D Castaing; B G Ericzon; J B Otte; K Rolles; B Ringe; M Sloof
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

6.  Natural history of chronic type B hepatitis.

Authors:  J H Hoofnagle; L B Seeff
Journal:  Prog Liver Dis       Date:  1982

7.  Cyclosporin A hepatotoxicity in 66 renal allograft recipients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Transplantation       Date:  1981-12       Impact factor: 4.939

8.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

9.  Natural history of chronic hepatitis B virus-related liver disease and its relationship to serum markers of viral replication.

Authors:  R Williams; G J Alexander
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

10.  Cyclosporin A-induced cholestasis. The mechanism in a rat model.

Authors:  B G Stone; M Udani; A Sanghvi; V Warty; K Plocki; C D Bedetti; D H Van Thiel
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.